 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | United States Air Force |
| Street 1: | School of Aerospace Medicine |
| Street 2: | 2510 Fifth Street, Building 840 |
| City: | Wright-Patterson Air Force Base |
| Province: | |
| Post Code: | 45433-7913 |
| Country: | United States of America |
| Phone: | 937 939-3216 |
| Email: | Christian.Benjamin @wpafb.af.mil |
| Web Site: | http://www.wpafb.af.mil/afrl/711hpw/usafsam.asp |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Countries |
| Organization Type - Primary: | Governmental Organization |
| Organization Type - Secondary: | None |
| Is your organization legally registered in your country: | Yes |
| Organization Reach: | International |
| Organization Description: | |
| USAF School of Aerspace Medicine (USAFSAM) USAFSAM is actively engaged in supporting multisectoral efforts to assess and enhance TB diagnostics. The objective is to facilitate identification of persons with evidence of M. tuberculosis infection (both latent and active) so prophylaxis or treatment can be instituted. |
|
| Total number of staff in your organization: | 100 + |
| Number of full-time staff who are directly involved with TB: | 6 - 10 |
| Number of part-time staff who are directly involved with TB: | 6 - 10 |
| Number of volunteers who are directly involved with TB: | 0 |
| What is your organization's annual budget (USD) dedicated to TB? | $1 MIL-$10 MIL |
| How did you hear about the Stop TB Partnership: | Other partners |
| Why do you wish join the Stop TB Partnership: | Network with other partners |
| Are you a member of a Stop TB national partnership: | United States of America |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| Supports development and periodic assessment of USAF/Department of Defense (DoD) TB screening/testing policies through the DoD's Joint Preventive Medicine Policy Group. Conducts and supports clinical trials to assess and enhance applications of TB diagnostics. Propose and Lead multiple Small Business Innovative Research (SBIR) efforts to develop novel TB diagnostics. |
|
Geographical Reach | |
| Which country is your headquarters located in: | United States of America |
| Which WHO region is the main focus of your work: | Global |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
United States of America |
Specializations | |
|
Delivery of health services and care Research and Development Technical Assistance |
Specializations in Countries | |
| Unknown |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
Laboratory Strengthening: USAFSAM used 3 SBIR Phase I and 1 SBIR Phase II efforts to develop automation enabling software for the QuantiFERON-TB Gold In-Tube assay (Cellestis, Inc) to facilitate assay reproducibility, reduce indeterminate rates, enable test validation and electronic results reporting. The outcome product (ImmunoFit; Celadon Laboratories, Inc) is now commercially available (see http://www.celadonlabs.com/products_immuno-fit.htm). New Diagnostics: USAFSAM/PHR has received $1,049,291 under SBIR O112-H05-3116 to fund 7 SBIR Phase I proposals for developing novel TB diagnostics. The TPOC is Dr. Donald Goodwin. |
|
Declaration | |
| Declaration of interests: No conflicts of interest to declare. | |
| Application date: | July 27, 2011 |
| Last updated: | September 29, 2011 |